Invention Grant
- Patent Title: Mutant human and simian immunodeficiency virus ENV proteins with reduced immunosuppressive properties
-
Application No.: US13707885Application Date: 2012-12-07
-
Publication No.: US09636396B2Publication Date: 2017-05-02
- Inventor: Thierry Heidmann
- Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE , UNIVERSITE PARIS-SUD XI , INSTITUT GUSTAVE ROUSSY , VIROXIS S.A.S.
- Applicant Address: FR Paris FR Orsay FR Villejuif FR Paris
- Assignee: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,UNIVERSITE PARIS-SUD XI,INSITUT GUSTAVE ROUSSY,VIROXIS S.A.S.
- Current Assignee: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,UNIVERSITE PARIS-SUD XI,INSITUT GUSTAVE ROUSSY,VIROXIS S.A.S.
- Current Assignee Address: FR Paris FR Orsay FR Villejuif FR Paris
- Agency: Young & Thompson
- Main IPC: A61K39/21
- IPC: A61K39/21 ; C07K14/16 ; C07K7/06 ; C07K7/08 ; C07K14/005 ; A61K39/12
Abstract:
A pharmaceutical composition includes, as active substance a mutated lentiviral ENV protein, substantially devoid of immunosuppressive properties or a variant of the mutated lentiviral ENV protein or a fragment of the above proteins, in association with a pharmaceutically acceptable carrier.
Public/Granted literature
- US20130149323A1 MUTATED LENTIVIRAL ENV PROTEINS AND THEIR USE AS DRUGS Public/Granted day:2013-06-13
Information query
